Evidence for incomplete replication of a penguin poxvirus in cells of mammalian origin

Journal of General Virology

Volumn 79, Issue 7, 1998, Pages 1637-1646

  Stannard, Linda M ^a   Marais, Dianne ^a   Kow, Daria ^a,b   Dumbell, Keith R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b State Vaccine Laboratory   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ARTICLE; CHICK EMBRYO; DNA REPLICATION; ELECTRON MICROSCOPY; EMBRYO; FIBROBLAST; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS MORPHOGENESIS; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; MAMMALIA; POXVIRIDAE; SIMIAE; SPHENISCIDAE; VACCINIA; VACCINIA VIRUS;

EID: 0031824053     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-7-1637     Document Type: Article

References (26)

1. Arhelger, R. B. & Randall, C. C. (1964). Electron microscopic observations on the development of fowlpox virus in chorioallantoic membrane. Virology 22, 59-66.
2. Baxby, D. & Paoletti, E. (1992). Potential use of non-replicating vectors as recombinant vaccines. Vaccine 10, 8-9.
3. Binns, M. M., Boursnell, M. E. G., Tomley, F. M. & Campbell, J. (1989). Analysis of the fowlpoxvirus gene encoding the 4b core polypeptide and demonstration that it possesses efficient promoter sequences. Virology 170, 288-291.
4. Cadoz, M., Strady, A., Meinier, B., Taylor, J., Tartaglia, J., Paoletti, E. & Plotkin, S. (1992). Immunisation with canarypox virus expressing rabies glycoprotein. Lancet 339, 1429-1432.
5. Cheville, N. F. (1966). Cytopathic changes in fowlpox (turkey origin) inclusion body formation. American Journal of Pathology 49, 723-736.
6. Cox, W. I., Tartaglia, J. & Paoletti, E. (1993). Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 195, 845-850.
7. Fenner, F. & Burnet, F. M. (1957). A short description of the poxvirus group (vaccinia and related viruses). Virology 4, 305-314.
8. Guillaume, J. C., Saiag, P., Wechsler, J., Lescs, M. C. & Roujeau, J. C. (1991). Vaccinia from recombinant virus expressing HIV genes. Lancet 337, 1034-1035.
9. Joklik, W. K. (1962). The purification of four strains of poxvirus. Virology 18, 9-18.
10. Kow, D. (1992). Characterization of avipoxviruses for use in recombinant vaccines. MSc thesis, University of Cape Town, South Africa.
11. MacGregor, G. R. & Caskey, C. T. (1989). Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Research 7, 2365.
12. MacGregor, G. R., Nolan, G. P., Fiering, S., Roederer, M. & Herzenberg, L. A. (1991). Use of E. coli lacZ (β-galactosidase) as a reporter gene. Methods in Molecular Biology 7, 217-325.
13. Moss B. (1990). Poxviridae and their replication. In Virology. 2nd edn, pp. 2079-2111. Edited by B. N. Fields and others. New York: Raven Press.
14. Perkus, M. E., Goebel, S. J., Davis, S. W., Johnson, G. P., Limbach, K., Norton, E. K. & Paoletti, E. (1990). Vaccinia host range genes. Virology 179, 276-286.
15. Purcell, D. A., Clarke, J. K., McFerran, J. B. & Hughes, D. A. (1972). The morphogenesis of pigeonpox virus. Journal of General Virology 15, 79-83.
16. Redfield, R. R., Wright, D. C., James, W. D., Jones, T. S., Brown, C. & Burke, D. S. (1987). Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. New England Journal of Medicine 316, 673-679.
17. Russell, W. C., Newman, C. & Williamson, D. H. (1975). A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature 253, 461-462.
18. Sodeik, B., Doms, R. W., Ericsson, M., Hiller, G., Machamer, C. E., van't Hof, W., van Meer, G., Moss, B. & Griffiths, G. (1993). Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic compartment and the Golgi stacks. Journal of Cell Biology 121, 521-541.
19. Somogyi, P., Frazier, J. & Skinner, M. A. (1993). Fowlpox virus host range restriction: gene expression, DNA replication and morphogenesis in nonpermissive mammalian cells. Virology 197, 439-444.
20. Spehner, D., Gillard, S., Drillien, R. & Kirn, A. (1988). A cowpox virus gene required for multiplication in Chinese hamster ovary cells. Journal of Virology 62, 1297-1304.
21. Stern, W. & Dales, S. (1976). Biogenesis of vaccinia: relationship of the envelope to virus assembly. Virology 75, 242-255.
22. Sutter, G. & Moss, B. (1992). Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proceedings of the National Academy of Sciences, USA 89, 10847-10851.
23. Tartaglia, J., Jarrett, O., Neil, J. C., Desmettre, P. & Paoletti, E. (1993). Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. Journal of Virology 67, 2370-2375.
24. Taylor, J., Weinberg, R., Languet, B., Desmettre, P. & Paoletti, E. (1988). Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 6, 497-503.
25. Taylor, J., Trimarchi, C., Weinberg, R., Languet, B., Guillemin, F., Desmettre, P. & Paoletti, E. (1991). Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 9, 190-193.
26. Taylor, J., Weinberg, R., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D., Appel, M., Norton, E. & Paoletti, E. (1992). Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187, 321-328.